Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass
- 1 August 1988
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 96 (2) , 332-341
- https://doi.org/10.1016/s0022-5223(19)35281-x
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Platelet Inhibitors and Hydroxyethyl Starch: Safe and Cost-Effective Interventions in Coronary Artery SurgeryThe Annals of Thoracic Surgery, 1985
- Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin.Circulation, 1984
- Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep.Circulation Research, 1983
- High-performance liquid chromatographic determination of dipyridamoleJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits.Circulation Research, 1980
- Mode of action of dipyridamole on human plateletsThrombosis Research, 1979
- Platelet aggregation IV. Platelet phosphodiesterase and its inhibition by vasodilatorsBiochemical and Biophysical Research Communications, 1971
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965